Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells
Authors
Keywords
-
Journal
Hormones & Cancer
Volume 11, Issue 3-4, Pages 182-190
Publisher
Springer Science and Business Media LLC
Online
2020-06-20
DOI
10.1007/s12672-020-00391-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
- (2020) Thanakorn Pungsrinont et al. Cell and Bioscience
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists
- (2019) Daniela Roell et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
- (2019) Tatsuo Sugawara et al. INTERNATIONAL JOURNAL OF CANCER
- The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform
- (2018) E. O. Mosaad et al. Scientific Reports
- Interference with the androgen receptor protein stability in therapy-resistant prostate cancer
- (2018) Gopinath Lakshmana et al. INTERNATIONAL JOURNAL OF CANCER
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- The dynamic nature of senescence in cancer
- (2018) Soyoung Lee et al. NATURE CELL BIOLOGY
- Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
- (2018) Marcello Tucci et al. OncoTargets and Therapy
- Context-dependent effects of cellular senescence in cancer development
- (2016) Pacome Lecot et al. BRITISH JOURNAL OF CANCER
- A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling
- (2016) Mohsen Esmaeili et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells
- (2016) Mohsen Esmaeili et al. Journal of Molecular Cell Biology
- Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens
- (2015) M. Thiele et al. CURRENT MEDICINAL CHEMISTRY
- Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
- (2015) Sven Perner et al. Oncotarget
- Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
- (2014) Julia Roediger et al. Molecular Cancer
- A Natural Androgen Receptor Antagonist Induces Cellular Senescence in Prostate Cancer Cells
- (2014) Wiebke Hessenkemper et al. MOLECULAR ENDOCRINOLOGY
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Overexpression of the VSSC-associated CAM, beta-2, enhances LNCaP cell metastasis associated behavior
- (2011) Keith H. Jansson et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started